(SALT LAKE CITY)—The University of Utah Health Sciences has named Harold A. "Jay" Vogelsang, CFRE, as its new associate vice president for development and chief development officer.
Vogelsang joins the University from the Mayo Clinic in Rochester, Minn., where he served in senior leadership roles including assistant chair for the Department of Development and principal gifts officer. He was recruited to the Mayo Clinic in 2005 to help lead its first comprehensive fundraising campaign – an effort that realized $2.35 billion in outright and deferred gifts in five years. In 2012 he assumed the role of principal gifts officer responsible for managing philanthropic relationships with 150 high-level, national benefactors in New York City, Los Angeles, San Francisco, the Northern Plains and the Rocky Mountains region. In addition, he led the Mayo Clinic's marketing and fundraising strategies for major West Coast markets.
Vogelsang's breadth of experience and leadership skills will help to broaden the Health Sciences fundraising base and attract more national donors, according to Vivian S. Lee, M.D., Ph.D., M.B.A., University of Utah senior vice president for health sciences. "We are excited to welcome Mr. Vogelsang to the University Health Sciences," says Lee, also dean of the School of Medicine and CEO of University of Utah Health Care. "His leadership and fundraising experience will be critically important as we expand our donor base to include more alumni and friends at the national level. We look forward to working with him as he leads our development efforts to even greater success in the years ahead."
Before joining the Mayo Clinic, Vogelsang led development at Carroll College, a private institution in Montana, and for the Montana Special Olympics and Montana Tech (of the University of Montana) Foundation. Vogelsang says he looks forward to leading the development program at a highly regarded health sciences center.
"The University of Utah Health Sciences Center is a powerhouse in academic medicine and I am thrilled to be a part of such a well-known and successful institution," he says. "I am especially looking forward to joining Dr. Lee and her colleagues as we work together to make her vision a reality."
Vogelsang officially begins work on Oct. 15, 2013.